New York, NY -- (SBWIRE) -- 11/15/2018 -- The new report "Myasthenia Gravis Disease Market, [By Disease Type (Imaging (X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Others), Blood Tests, Electrodiagnostic, and Edrophonium Test), By Treatment (Medication, Surgery, and HSCT), By End-User (Hospitals, Clinics, and Academic Research Institutes) By Region]: Market Size & Forecast, 2018 – 2026" The global Myasthenia Gravis Disease Market is estimated to reach USD 2,538.6 million by 2026 from USD 1,012.2 million in 2017. The market is anticipated to grow at a CAGR of 10.8% during the forecast period.

Request for a sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-market/request-for-free-sample

Myasthenia gravis disease is a neuromuscular ailment that causes the weakness of skeletal muscles, that are used for body movement. MG Disease is generally caused by an autoimmune disease when communication between muscles and nerve cells becomes impaired. According to the Myasthenia Gravis Foundation of America, MG is relatively rare condition that affects approximately 14 to 20 out of every 100,000 people in the United States. Moreover, according to the National Institutes of Health (NIH), MG typically occurs in people over the age of 40 where Women are more likely to be diagnosed as younger adults. There is no exact cure for the MG disease. However, through appropriate diagnosis and medication treatment, the disease can be controlled over the time. The symptoms of the MG disease include facial paralysis, difficulty breathing due to muscle weakness, difficulty swallowing or chewing, drooping of eyelids, and trouble in walking.

The global Myasthenia Gravis Disease market is majorly driven by the factor such as high incidences of neuromuscular disorders. Moreover, increasing number of clinical facilities across the region and rising consciousness about the treatment are other factors driving the market growth. However, the unfamiliarity with early symptoms as well as signs and high cost associated with the treatment are factors hampering the market growth.

Browse Complete Summary of this report @ https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-market/

The report provides an extensive qualitative and quantitative analysis of the market trends and growth prospects of the Global Myasthenia Gravis Disease Market, 2017-2026. This report comprises a detailed geographic distribution of the market across North America, Europe, APAC, Latin America, and MEA. North America is further segmented into U.S., Canada, and Mexico. Europe is divided into Germany, UK, Italy, France, and Rest of Europe. Asia-Pacific is bifurcated into China, India, Japan, and Rest of Asia-Pacific. In 2017, North America Myasthenia Gravis Disease Market was estimated to dominate the market growth due to high occurrence of disease such in North America.

Competitive Landscape and Key Vendors

The leading companies profiled in the Myasthenia Gravis Disease Market report include Alexion Pharmaceutical Inc., Avadel Pharmaceuticals plc, CSL Behring, Grifols S.A., Baxter International Inc., Shire plc, Novartis AG, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, and Valeant Pharmaceuticals International Inc.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-market/inquire-before-buying

Key Segments

Diagnosis

- Imaging
X-ray
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Others

- Blood Tests
- Electrodiagnostic
- Edrophonium Test

Treatment

- Medication
- Surgery
- HSCT

End-User

- Hospitals
- Clinics
- Academic Research Institutes

Region

- North America

o U.S.
o Canada
o Mexico

- Europe

o Germany
o UK
o France
o Italy
o Rest of Europe

- Asia-Pacific

o China
o India
o Japan
o Rest of Asia-Pacific

- Latin America

o Brazil
o Rest of Latin America

- Middle East and Africa

Don't miss out on business opportunities in Myasthenia Gravis Disease Market. Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-market/speak-to-analyst

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: neel@polarismarketresearch.com
Web: www.polarismarketresearch.com